Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma.

Silver, Jared; Bogart, Michael; Packnett, Elizabeth; Wu, Juan; McMorrow, Donna; Hahn, Beth

Silver, Jared; Bogart, Michael; Packnett, Elizabeth; Wu, Juan; McMorrow, Donna; Hahn, Beth.

Afiliación

Silver J; US Medical Affairs, GSK, Research Triangle Park, NC, USA.
Bogart M; US Medical Affairs, GSK, Research Triangle Park, NC, USA.
Packnett E; Life Sciences, IBM Watson Health, Bethesda, MD, USA.
Wu J; Life Sciences, IBM Watson Health, Bethesda, MD, USA.
McMorrow D; Life Sciences, IBM Watson Health, Bethesda, MD, USA.
Hahn B; US Medical Affairs, GSK, Research Triangle Park, NC, USA.

J Asthma Allergy ; 13: 689-699, 2020.

Article en En | MEDLINE | ID: mdl-33364788

Palabras clave

claims; healthcare resource utilization; mepolizumab; oral corticosteroids; real-world study; severe asthma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Asthma Allergy Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google